5月21日周三盘中，医渡科技（02158）股价出现显著上涨，涨幅高达5.66%，引发市场关注。截至发稿，该股报5.94港元，成交额超7000万港元。
分析人士认为，医渡科技股价上涨主要受益于AI医疗领域的广阔前景。财信证券表示，未来医疗行业有望依托企业技术平台化、AI诊疗拓展、消费医疗延伸突破等实现多维发展。随着人工智能技术的持续发展和群众医疗健康需求持续提升，AI医疗领域有望进一步扩容。
值得注意的是，医渡科技在AI医疗领域已取得显著成果。据东北证券研报，公司目前已向105家中国顶级医院以及40个监管机构和政策制定者提供解决方案，覆盖超过2800家医院。公司推出的"大数据+大语言模型"双中台解决方案，有助于客户进行科研和临床研究。此外，公司在医疗、制药、健康保险等多业务场景实现了广泛应用，"医—药—险—患"全场景解决方案已全面落地。这些因素都为公司在AI医疗领域的持续发展奠定了坚实基础，也是投资者看好该股的重要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.